Vanguard Group Inc 2seventy Bio, Inc. Transaction History

Vanguard Group Inc

$5.57 Trillion
Q4 2024

A detailed history of Vanguard Group Inc transactions in 2seventy Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,761,245 shares of TSVT stock, worth $9.82 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,761,245

Previous 3,772,232 0.29%

Holding current value

$9.82 Million

Previous $17.8 Million 37.89%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 11, 2025	SELL	$2.89 - $5.21 $31,752 - $57,242	-10,987 Reduced 0.29%	3,761,245 $11.1 Million
Q3 2024 Nov 13, 2024	BUY	$3.85 - $5.05 $550,977 - $722,710	143,111 Added 3.94%	3,772,232 $17.8 Million
Q2 2024 Aug 13, 2024	SELL	$3.6 - $5.79 $369,208 - $593,810	-102,558 Reduced 2.75%	3,629,121 $14 Million
Q1 2024 May 10, 2024	SELL	$3.09 - $6.0 $785,141 - $1.52 Million	-254,091 Reduced 6.37%	3,731,679 $20 Million
Q4 2023 Feb 14, 2024	BUY	$1.57 - $4.58 $395,472 - $1.15 Million	251,893 Added 6.75%	3,985,770 $17 Million
Q3 2023 Nov 14, 2023	BUY	$3.14 - $11.2 $804,477 - $2.87 Million	256,203 Added 7.37%	3,733,877 $14.6 Million
Q2 2023 Aug 14, 2023	BUY	$8.45 - $12.48 $4.85 Million - $7.16 Million	573,640 Added 19.75%	3,477,674 $35.2 Million
Q1 2023 May 15, 2023	BUY	$9.21 - $14.98 $4.6 Million - $7.49 Million	499,805 Added 20.79%	2,904,034 $29.6 Million
Q4 2022 Feb 10, 2023	BUY	$8.57 - $17.0 $413,896 - $821,032	48,296 Added 2.05%	2,404,229 $22.5 Million
Q3 2022 Nov 14, 2022	BUY	$12.56 - $17.54 $324,676 - $453,409	25,850 Added 1.11%	2,355,933 $34.3 Million
Q2 2022 Aug 12, 2022	BUY	$10.55 - $18.81 $10 Million - $17.9 Million	949,757 Added 68.81%	2,330,083 $30.8 Million
Q1 2022 May 13, 2022	SELL	$11.67 - $26.72 $5.6 Million - $12.8 Million	-479,623 Reduced 25.79%	1,380,326 $23.5 Million
Q4 2021 Feb 14, 2022	BUY	$13.77 - $42.56 $25.6 Million - $79.2 Million	1,859,949 New	1,859,949 $47.7 Million

Others Institutions Holding TSVT

# of Institutions

127

Shares Held

44.8M

Call Options Held

17.3K

Put Options Held

2.9K

View Full List

About 2seventy bio, Inc.

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $98.9M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

More about TSVT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc 2seventy Bio, Inc. Transaction History